ArticleInternational journal of biomaterials2026
Therapeutic Effect of Eugenol-Loaded Chitosan Nanoparticles Against
Article in International journal of biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Therapeutic Effect of Eugenol-Loaded Chitosan Nanoparticles AgainstInternational journal of biomaterials · 2026Article
- New concepts of chitosan-based mucosal formulations for supporting control of the gastric pathogenFrontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Eugenol is a phenolic compound known for its antimicrobial, antifungal, and antioxidant properties. Its encapsulation in chitosan nanoparticles (EuChiNPs) enhances stability and therapeutic efficacy. Objectives: This study aimed to investigate the effects of EuChiNPs on Methods: EuChiNPs were synthesized and characterized using DLS, TEM, and FTIR techniques. A total of 42 male Wistar rats were divided into six groups, including controls, Results: The combination of EuChiNPs and standard antibiotics significantly reduced the expression of inflammatory markers interleukin-1 beta (IL-1β) and interleukin-8 (IL-8). Serum levels of IL-1β, IL-8, and TNF-α were markedly decreased in the combination group compared with antibiotics alone ( Conclusion: EuChiNPs demonstrated strong anti-inflammatory and antiapoptotic effects, especially when combined with standard antibiotics. This novel approach promises to improve
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.